Reliability and Validity of the French Version of the Virtual Reality Sickness Questionnaire

Not Applicable

Completed

• Conditions: Virtual Reality Cyber Sickness
• Interventions: Diagnostic Test: Use of Measurement Instrument

• Registration Number: NCT06466590
• Lead Sponsor: Pôle Saint Hélier

Brief Summary

This is a multicenter, controlled, non-randomized interventional clinical study, with minimal risks and constraints, aimed at verifying the reliability of the French version of the VRSQ questionnaire (VRSQ-F) and the validity of the VRSQ-F score by comparing it with the SSQ score.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2024-06-07
• Study First Submitted QC: 2024-06-13
• Study First Posted: 2024-06-20
• Study Start: 2024-07-01
• Status Verified: 2025-05
• Primary Completion: 2025-05-14
• Study Completion: 2025-05-14
• Last Update Submitted: 2025-05-26
• Last Update Posted: 2025-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 88

Inclusion Criteria

For Healthy people :

• Men or women aged 18 to 65
• Person affiliated to a social security scheme
• Healthy person with no particular medical condition
• Having given their consent to participate in the research

For patients :

• Men or women aged 18 to 65
• Persons affiliated to a social security scheme
• People undergoing regular rehabilitation, walking or in a wheelchair, who can use a virtual reality solution as part of their care.
• Having given their consent to take part in the research

Exclusion Criteria

• Vestibular and cardiac pathologies, and major visual disorders not compatible with virtual reality rehabilitation
• Cognitive and language disorders
• Persons under legal protection
• Pregnant women
• MSSQ greater than 15
• People suffering from photosensitive epilepsy
• Persons under the influence of medication that may impair drugs or alcohol
• Participant with an implanted medical device that may be affected by radio waves emitted by compatible third-party equipment (e.g. : Pacemaker)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Single Group	Use of Measurement Instrument	Participants will be asked to use the measurement instrument VRSQ-F on two separate occasions under identical conditions to assess its test-retest reliability and asked to use the SSQ for validity. Each session will involve completing the measurement protocol as specified.

Primary Outcome Measures

Name	Time	Method
Check the validity of the VRSQ-F score by comparing it with the SSQ score	Immediately after exercises	Criteria validity between SSQ and VRSQ-F. SSQ questionnaire with 16 questions scoring from 0 to 48 VRSQ-F questionnaire with 9 questions from 0 to 27
Reliability of VRSQ-F (Virtual Reality Sickness Questionnaire) using the intraclass correlation coefficient between measurements immediately after VR exercises and 15 min after and Cronbach coefficient of the VRSQ-F questionnaire	Immediately after exercises	Reliability of VRSQ-F (Virtual Reality Sickness Questionnaire) using the intraclass correlation coefficient between measurements immediately after VR exercises and 15 min after and Cronbach coefficient of the VRSQ-F questionnaire

Secondary Outcome Measures

Name	Time	Method
Calculate the minimum detectable change in the questionnaire	Immediately after exercises	Clinimetric quality: Calculation of the standard error of measurement SEM and the minimum detectable change MDC

Trial Locations

Locations (3)

Centre de Rééducation Fonctionnelle Neurologique PROPARA; 🇫🇷 Montpellier, France

Pôle Saint-Hélier; 🇫🇷 Rennes, France

Fondation Ildys; 🇫🇷 Roscoff, France